COHANCE LIFESCIENCES

As many as 3.39 crore shares, or 8.9% equity of Cohance Lifesciences worth ₹3,073 crore changed hands via block deals on Thursday, September 18. The stock fell over 6% in opening trading. Earlier in the day, sources told CNBC-TV18 that Jusmiral Holdings was likely to sell 8.9% stake or 34.1 million shares in Cohance Lifesciences for $350 million via block deals. A day prior, sources had told CNBC-TV18 that Jusmiral Holdings was to sell up to 5.1% of its stake in Cohance Lifesciences Ltd. via block deals.